Johnson & Johnson’s DE STSF platform secures FDA approval

J&J has secured approval from the US Food and Drug Administration (FDA) for its Dual Energy Thermocool Smarttouch SF Platform (DE STSF). The platform is integrated with the CARTO ecosystem, incorporating advanced mapping, imaging, and PF Index guidance features. Following the FDA authorisation, J&J expects the first use of the DE STSF platform in the US to occur later this year. Credit: MAD.vertise / Shutterstock.com. Johnson & Johnson (J&J) has secured approval from the US Food and Drug Administration (FDA) for its Dual Energy Thermocool Smarttouch SF Platform (DE STSF). The system is designed to support electrophysiologists in performing catheter…

Source: Medical Device Network